María D.
Odero
Forscherin bis um 2024
Universidad de Salamanca
Salamanca, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Salamanca (5)
2021
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
2013
-
Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines
Cancer Letters, Vol. 334, Núm. 2, pp. 302-310
2006
-
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain
Leukemia Research, Vol. 30, Núm. 8, pp. 943-948
2003
-
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study
Leukemia, Vol. 17, Núm. 10, pp. 2016-2024